From: Circulating ANGPTL8 levels and risk of kidney function decline: Results from the 4C Study
ANGPTL8 | Model 1 | Model 2 | Model 3 | IPTW model |
---|---|---|---|---|
Q1 (Reference) | 1 | 1 | 1 | Â |
Q2 (HR, 95% CI) | 1.91 (1.04–3.51) | 1.86 (0.98–3.54) | 1.52 (0.79–2.94) | 1.72 (1.10–2.68) |
Q3 (HR, 95% CI) | 1.74 (0.93–3.25) | 1.45 (0.74–2.85) | 1.43 (0.73–2.80) | 1.36 (0.86–2.14) |
Q4 (HR, 95% CI) | 4.66 (2.70–8.05) | 3.99 (2.21–7.20) | 2.59 (1.41–4.77) | 1.73 (1.27–2.36) |
Per-SD increase | 1.64 (1.45–1.85) | 1.55 (1.36–1.77) | 1.31 (1.13–1.51) | - |